NRAS and Miyoshi myopathy: In the case of myeloma, a recent report of whole genome sequencing of tumors from 38 MM patients demonstrated that exactly 50% of these patients harbored either K-Ras or N-Ras coding mutations, underscoring the importance of these oncogenes in MM (Chapman et al., 2011).